000			01456 a2200421 4500
005			20250511202341.0
264		0	_c19920221
008			199202s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/0735-1097(92)90480-b _2doi
040			_aNLM _beng _cNLM
100	1		_aDe Jaegere, P P
245	0	0	_aIntracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cFeb 1992
300			_a289-94 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aCase-Control Studies
650	0	4	_aCerebral Hemorrhage _xchemically induced
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aMale
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aNetherlands _xepidemiology
650	0	4	_aProspective Studies
650	0	4	_aRegistries
650	0	4	_aRegression Analysis
650	0	4	_aRisk Factors
650	0	4	_aStreptokinase _xadverse effects
650	0	4	_aThrombolytic Therapy _xadverse effects
700	1		_aArnold, A A
700	1		_aBalk, A H
700	1		_aSimoons, M L
773	0		_tJournal of the American College of Cardiology _gvol. 19 _gno. 2 _gp. 289-94
856	4	0	_uhttps://doi.org/10.1016/0735-1097(92)90480-b _zAvailable from publisher's website
999			_c1738752 _d1738752